From: The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial
Parameter
BEXIDEM
N = 75
BCG
N = 78
Age
Mean
63
62.8
Median
64.5
Range
43-83
27-83
Sex
Male
62 (83%)
64(82%)
Female
13 (17%)
14 (18%)
Ethnic Group
Caucasian
75 (100%)
77 (99%)
Mediterranean
0 (0%)
1 (1%)